A/Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital and a Research conjoint with the School of Pharmacy (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 7 PhD students and 2 MPhil students who are conducting research related to medication safety, health informatics and clinical pharmacy. He has a strong interest in designing, testing and monitoring individualised dosing strategies for high-risk patients in the hospital setting. Michael has many significant research relationships in hospital, university, and industry settings. He is a member of the SoP research committee.
Journal Article: The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review
Costello, Jaclyn, Barras, Michael, Foot, Holly and Cottrell, Neil (2023). The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. Exploratory Research in Clinical and Social Pharmacy, 11 100305, 100305. doi: 10.1016/j.rcsop.2023.100305
Journal Article: Investigating the Natural Disaster Preparedness of Hospital Pharmacists Across Four Hospitals in Australia
McCourt, Elizabeth, Anderson, Amelia, Hollingworth, Samantha and Barras, Michael (2023). Investigating the Natural Disaster Preparedness of Hospital Pharmacists Across Four Hospitals in Australia. Prehospital and Disaster Medicine, 38 (S1), s112-s112. doi: 10.1017/s1049023x23003035
Journal Article: Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study
Paradissis, Chariclia, De Guzman, Keshia R., Barras, Michael, La Caze, Adam, Winckel, Karl, Taufatofua, Natasha and Falconer, Nazanin (2023). Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study. Exploratory Research in Clinical and Social Pharmacy, 9 100241, 100241. doi: 10.1016/j.rcsop.2023.100241
REducing hospital re-admission for high-risk CARDiology patients
(2023–2027) MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
(2023) Metro South Hospital and Health Service
(2019–2021) Metro South Hospital and Health Service
Medication harm in patients after Acute Myocardial Infarction
Doctor Philosophy
A pharmacist to improve medication management and patient outcomes for critically ill patients in the emergency department.
Doctor Philosophy
Patient-Centred Pharmacy Care in the hospital setting
Doctor Philosophy
Peri-procedural anticoagulation
Barras, Michael (2015). Peri-procedural anticoagulation. Anticoagulation management: a guide for pharmacists . (pp. 179-199) edited by Anne Rose. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-22602-6_8
Dose individualization of drugs based on body composition
Barras, Michael and Green, Bruce (2009). Dose individualization of drugs based on body composition. Heart disease in men. (pp. 219-242) edited by Alice B. Todd and Margo H. Mosley. New York, NY, United States: Nova Science Publishers.
Costello, Jaclyn, Barras, Michael, Foot, Holly and Cottrell, Neil (2023). The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. Exploratory Research in Clinical and Social Pharmacy, 11 100305, 100305. doi: 10.1016/j.rcsop.2023.100305
McCourt, Elizabeth, Anderson, Amelia, Hollingworth, Samantha and Barras, Michael (2023). Investigating the Natural Disaster Preparedness of Hospital Pharmacists Across Four Hospitals in Australia. Prehospital and Disaster Medicine, 38 (S1), s112-s112. doi: 10.1017/s1049023x23003035
Paradissis, Chariclia, De Guzman, Keshia R., Barras, Michael, La Caze, Adam, Winckel, Karl, Taufatofua, Natasha and Falconer, Nazanin (2023). Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study. Exploratory Research in Clinical and Social Pharmacy, 9 100241, 100241. doi: 10.1016/j.rcsop.2023.100241
Snoswell, Centaine L., De Guzman, Keshia R. and Barras, Michael (2023). Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics. Internal Medicine Journal, 53 (1) imj.15504, 95-103. doi: 10.1111/imj.15504
Gurunathan, Usha, Barras, Michael, McDougall, Catherine, Nandurkar, Harshal and Eley, Victoria (2022). Obesity and the risk of venous thromboembolism after major lower limb orthopaedic surgery: a literature review. Thrombosis and Haemostasis, 122 (12), 1969-1979. doi: 10.1055/s-0042-1757200
The effect of digitisation on the safe management of anticoagulants
Austin, Jodie Ann, Barras, Michael, Woods, Leanna Sarah and Sullivan, Clair (2022). The effect of digitisation on the safe management of anticoagulants. Applied Clinical Informatics, 13 (04), 845-856. doi: 10.1055/a-1910-4339
Abdel-Hafez, Ahmad, Scott, Ian A., Falconer, Nazanin, Canaris, Stephen, Bonilla, Oscar, Marxen, Sven, Van Garderen, Aaron and Barras, Michael (2022). Predicting therapeutic response to unfractionated heparin therapy: a methodological pilot study using machine learning. Interactive Journal of Medical Research, 11 (2) e34533. doi: 10.2196/34533
Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
Lam, Jonathan Yong Jie, Barras, Michael, Scott, Ian A., Long, Duncan, Shafiee Hanjani, Leila and Falconer, Nazanin (2022). Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm. Drugs & Aging, 39 (8), 671-672. doi: 10.1007/s40266-022-00956-9
Treatment strategies for clozapine-induced hypotension: a systematic review
Tanzer, Timothy David, Brouard, Thomas, Dal Pra, Samuel, Warren, Nicola, Barras, Michael, Kisely, Steve, Brooks, Emily and Siskind, Dan (2022). Treatment strategies for clozapine-induced hypotension: a systematic review. Therapeutic Advances in Psychopharmacology, 12, 1-16. doi: 10.1177/20451253221092931
Scoping review of studies evaluating frailty and its association with medication harm
Lam, Jonathan Yong Jie, Barras, Michael, Scott, Ian A., Long, Duncan, Shafiee Hanjani, Leila and Falconer, Nazanin (2022). Scoping review of studies evaluating frailty and its association with medication harm. Drugs and Aging, 39 (5), 333-353. doi: 10.1007/s40266-022-00940-3
Whatmough, Sarah, Snoswell, Centaine, Callaghan, Gavin, Lucas, Grace, Barras, Michael and Morris, Christopher (2022). Infusion reaction incidence after switching all patients to an infliximab biosimilar in an Australian hospital. Journal of Pharmacy Practice and Research, 52 (4), 322-325. doi: 10.1002/jppr.1811
Snoswell, Centaine L., Cossart, Amelia R., Chevalier, Bernadette and Barras, Michael (2022). Benefits, challenges and contributors to the introduction of new hospital-based outpatient clinic pharmacist positions. Exploratory Research in Clinical and Social Pharmacy, 5 100119, 100119. doi: 10.1016/j.rcsop.2022.100119
Lim, Han Chang, Austin, Jodie A., van der Vegt, Anton H., Rahimi, Amir Kamel, Canfell, Oliver J., Mifsud, Jayden, Pole, Jason D., Barras, Michael A., Hodgson, Tobias, Shrapnel, Sally and Sullivan, Clair M. (2022). Toward a learning health care system: a systematic review and evidence-based conceptual framework for implementation of clinical analytics in a digital hospital. Applied Clinical Informatics, 13 (02), 339-354. doi: 10.1055/s-0042-1743243
Thomas, Emma, de Camargo Catapan, Soraia, M. Haydon, Helen, Barras, Michael and Snoswell, Centaine (2022). Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: a multi-method study. Research in Social and Administrative Pharmacy, 18 (9), 3602-3611. doi: 10.1016/j.sapharm.2022.02.003
Tanzer, Timothy, Warren, Nicola, McMahon, Laura, Barras, Michael, Kisely, Steve, Brooks, Emily, Wong, Emily and Siskind, Dan (2022). Treatment strategies for clozapine induced nocturnal enuresis and urinary incontinence: a systematic review. CNS Spectrums, 28 (2), 1-12. doi: 10.1017/s1092852922000050
Falconer, Nazanin, Barras, Michael, Abdel-Hafiz, Ahmad, Radburn, Sam and Cottrell, Neil (2022). Evaluation of two European risk models for predicting medication harm in an Australian patient cohort. European Journal of Clinical Pharmacology, 78 (4), 679-686. doi: 10.1007/s00228-021-03271-1
The right time and place: the need for seven‐day pharmacist service models
Falconer, Nazanin, Snoswell, Centaine, Morris, Christopher and Barras, Michael (2021). The right time and place: the need for seven‐day pharmacist service models. Journal of Pharmacy Practice and Research, 51 (6), 444-455. doi: 10.1002/jppr.1761
Systematic review of machine learning models for personalised dosing of heparin
Falconer, Nazanin, Abdel-Hafez, Ahmad, Scott, Ian A., Marxen, Sven, Canaris, Stephen and Barras, Michael (2021). Systematic review of machine learning models for personalised dosing of heparin. British Journal of Clinical Pharmacology, 87 (11) bcp.14852, 4124-4139. doi: 10.1111/bcp.14852
Medicines, including complementary medicines, to avoid in liver dysfunction
Callaghan, Gavin and Barras, Michael (2021). Medicines, including complementary medicines, to avoid in liver dysfunction. Australian Pharmacist.
Patient harm from cardiovascular medications
Paradissis, Chariclia, Cottrell, Neil, Coombes, Ian, Scott, Ian, Wang, William and Barras, Michael (2021). Patient harm from cardiovascular medications. Therapeutic Advances in Drug Safety, 12, 204209862110274. doi: 10.1177/20420986211027451
An evaluation of pharmacist activity in hospital outpatient clinics
Snoswell, Centaine L., Draper, Megan J. and Barras, Michael (2021). An evaluation of pharmacist activity in hospital outpatient clinics. Journal of Pharmacy Practice and Research, 51 (4) jppr.1729, 328-332. doi: 10.1002/jppr.1729
Aziz, E., Barras, M., Snoswell, C. and Falconer, N. (2021). Determining causality, severity and preventability of inpatient medication harm, including related hospital-acquired complications, using clinical coding data. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 5 (1-2), 46-52. doi: 10.24080/grit.1308
Safe and effective digital anticoagulation: a continuous iterative improvement approach
Austin, Jodie A., Barras, Michael A. and Sullivan, Clair M. (2021). Safe and effective digital anticoagulation: a continuous iterative improvement approach. ACI Open, 05 (02), e116-e124. doi: 10.1055/s-0041-1736631
Platelet function assays for the diagnosis of aspirin resistance
Van Oosterom, Nameer, Barras, Michael, Cottrell, Neil and Bird, Robert (2021). Platelet function assays for the diagnosis of aspirin resistance. Platelets, 33 (3), 1-10. doi: 10.1080/09537104.2021.1942816
What is needed to mainstream artificial intelligence in health care?
Scott, Ian A., Abdel-Hafez, Ahmad, Barras, Michael and Canaris, Stephen (2021). What is needed to mainstream artificial intelligence in health care?. Australian Health Review, 45 (5), 591-596. doi: 10.1071/ah21034
A narrative review of aspirin resistance in VTE prophylaxis for orthopaedic surgery
van Oosterom, Nameer, Barras, Michael, Bird, Robert, Nusem, Iulian and Cottrell, Neil (2020). A narrative review of aspirin resistance in VTE prophylaxis for orthopaedic surgery. Drugs, 80 (18), 1889-1899. doi: 10.1007/s40265-020-01413-w
Development and validation of the Adverse Inpatient Medication Event Model (AIME)
Falconer, Nazanin, Barras, Michael, Abdel‐Hafez, Ahmad, Radburn, Sam and Cottrell, Neil (2020). Development and validation of the Adverse Inpatient Medication Event Model (AIME). British Journal of Clinical Pharmacology, 87 (3) bcp.14560, 1512-1524. doi: 10.1111/bcp.14560
Transit Care Hub pharmacist: improving patient flow within the hospital
Snoswell, Centaine, Jensen, Estelle, Wang, Nancy, Shah, Krishna, Currey, Elizabeth and Barras, Michael (2020). Transit Care Hub pharmacist: improving patient flow within the hospital. International journal of clinical pharmacy, 42 (5), 1319-1325. doi: 10.1007/s11096-020-01092-3
Integrating a pharmacist into the perioperative setting
Forrester, Tori G., Sullivan, Sara, Snoswell, Centaine L., Pillans, Peter, Barras, Michael and Sturgess, David (2020). Integrating a pharmacist into the perioperative setting. Australian Health Review, 44 (4), 563-568. doi: 10.1071/ah19126
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2020). Assessing communication behaviours of hospital pharmacists: how well do the perspectives of pharmacists, patients, and an independent observer align?. Journal of Language and Social Psychology, 39 (5-6), 626-652. doi: 10.1177/0261927x20909867
Unfractionated heparin dosing in obese patients
George, Christopher, Barras, Michael, Coombes, Judith and Winckel, Karl (2020). Unfractionated heparin dosing in obese patients. International Journal of Clinical Pharmacy, 42 (2), 462-473. doi: 10.1007/s11096-020-01004-5
Austin, Jodie, Barras, Michael and Sullivan, Clair (2020). Interventions designed to improve the safety and quality of therapeutic anticoagulation in an inpatient electronic medical record. International Journal of Medical Informatics, 135 104066, 104066. doi: 10.1016/j.ijmedinf.2019.104066
van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2020). Comment on: “Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study”. Clinical Drug Investigation, 40 (3), 287-288. doi: 10.1007/s40261-020-00889-4
Economic benefits of pharmacy technicians practicing at advanced scope: a systematic review
Banks, Vivien L., Barras, Michael and Snoswell, Centaine L. (2020). Economic benefits of pharmacy technicians practicing at advanced scope: a systematic review. Research in Social and Administrative Pharmacy, 16 (10), 1344-1353. doi: 10.1016/j.sapharm.2020.01.007
Finn, Shannon, D’arcy, Emily, Donovan, Peter, Kanagarajah, Shanthi and Barras, Michael (2020). A randomised trial of pharmacist-led discharge prescribing in an Australian geriatric evaluation and management service. International Journal of Clinical Pharmacy, 43 (4), 847-857. doi: 10.1007/s11096-020-01184-0
Identifying medication harm in hospitalised patients: a bimodal, targeted approach
Falconer, Nazanin, Spinewine, Anne, Doogue, Matthew P. and Barras, Michael (2020). Identifying medication harm in hospitalised patients: a bimodal, targeted approach. Therapeutic Advances in Drug Safety, 11, 2042098620975516. doi: 10.1177/2042098620975516
Mohamed, Raafat, Cao, Yingnan, Afroz, Rizwana, Xu, Suowen, Ta, Hang T., Barras, Michael, Zheng, Wenhua, Little, Peter J. and Kamato, Danielle (2020). ROS directly activates transforming growth factor β type 1 receptor signalling in human vascular smooth muscle cells. Biochimica et Biophysica Acta. General Subjects, 1864 (1) 129463, 129463. doi: 10.1016/j.bbagen.2019.129463
Frazer, Andrew, Rowland, James, Mudge, Alison, Barras, Michael, Martin, Jennifer and Donovan, Peter (2019). Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. European Journal of Clinical Pharmacology, 75 (12), 1645-1657. doi: 10.1007/s00228-019-02752-8
Pharmacy technicians practicing in advanced scope roles
Banks, Vivien L., Barras, Michael and Snoswell, Centaine L. (2019). Pharmacy technicians practicing in advanced scope roles. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (3) doi:10.24080/grit.1200, 174-177.
Quantifying pharmacist involvement in care for patients who experience multiple ward transitions
Snoswell, Centaine L., Skopp, Tom V. and Barras, Michael (2019). Quantifying pharmacist involvement in care for patients who experience multiple ward transitions. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (3) doi: 10.24080/grit.1202, 209-210.
How hospital pharmacists prioritise patients at high-risk for medication harm
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2019). How hospital pharmacists prioritise patients at high-risk for medication harm. Research in Social and Administrative Pharmacy, 15 (10), 1266-1273. doi: 10.1016/j.sapharm.2018.11.003
Developing preliminary steps in a pharmacist communication - patient outcome pathway
Chevalier, Bernadette, Watson, Bernadette M., Barras, Michael A. and Cottrell, William N. (2019). Developing preliminary steps in a pharmacist communication - patient outcome pathway. Canadian Journal of Hospital Pharmacy, 72 (4), 271-281. doi: 10.4212/cjhp.v72i4.2913
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of Thrombosis and Thrombolysis, 48 (3), 387-393. doi: 10.1007/s11239-019-01847-4
Conversion of other opioids to methadone: a retrospective comparison of two methods
Lukin, Bill, Greenslade, Jaimi, Kearney, Alison Mary, Douglas, Carol, Howell, Tegwen, Barras, Michael and Good, Phillip (2019). Conversion of other opioids to methadone: a retrospective comparison of two methods. BMJ Supportive and Palliative Care, 10 (2), bmjspcare-2018. doi: 10.1136/bmjspcare-2018-001645
Defining and classifying terminology for medication harm: a call for consensus
Falconer, Nazanin, Barras, Michael, Martin, Jennifer and Cottrell, Neil (2019). Defining and classifying terminology for medication harm: a call for consensus. European Journal of Clinical Pharmacology, 75 (2), 137-145. doi: 10.1007/s00228-018-2567-5
Primary and secondary prevention of stroke
Barras, M.A. and Winckel, K. (2019). Primary and secondary prevention of stroke. Australian Pharmacist, 12, 42-51.
Therapeutic drug monitoring: using Bayesian methods to evaluate hospital practice
Donagher, Joni and Barras, Michael A. (2018). Therapeutic drug monitoring: using Bayesian methods to evaluate hospital practice. Journal of Pharmacy Practice and Research, 48 (6), 522-529. doi: 10.1002/jppr.1432
Scott, Ian A., Pillans, Peter I., Barras, Michael and Morris, Christopher (2018). Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Therapeutic Advances in Drug Safety, 9 (9), 559-573. doi: 10.1177/2042098618784809
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2018). Reply to Iuga and Genaidy "Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes". British Journal of Clinical Pharmacology, 84 (8), 1857-1857. doi: 10.1111/bcp.13633
Endothelial function and dysfunction: impact of metformin
Nafisa, Asma, Gray, Susan G., Cao, Yingnan, Wang, Tinghuai, Xu, Suowen, Wattoo, Feroza H., Barras, Michael, Cohen, Neale, Kamato, Danielle and Little, Peter J. (2018). Endothelial function and dysfunction: impact of metformin. Pharmacology and Therapeutics, 192, 150-162. doi: 10.1016/j.pharmthera.2018.07.007
Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A., Cottrell, William N. and Angus, Daniel J. (2018). Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions. PLoS One, 13 (5) e0197288, e0197288. doi: 10.1371/journal.pone.0197288
The SHPA Medal of Merit 2017 Oration
Barras, Michael (2018). The SHPA Medal of Merit 2017 Oration. Pharmacy Growth, Research, Innovation and Training, 2 (1). doi: 10.24080/grit.1085
Systematic review of predictive risk models for adverse drug events in hospitalised patients
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2018). Systematic review of predictive risk models for adverse drug events in hospitalised patients. British journal of clinical pharmacology, 84 (5), 846-864. doi: 10.1111/bcp.13514
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2018). Monitoring of tobramycin exposure: what is the best estimation method and sampling time for clinical practice?. Clinical Pharmacokinetics, 58 (3), 389-399. doi: 10.1007/s40262-018-0707-9
Bayesian estimation of tobramycin exposure in patients with cystic fibrosis — an update
Gao, Yanhua, Barras, Michael and Hennig, Stefanie (2017). Bayesian estimation of tobramycin exposure in patients with cystic fibrosis — an update. Antimicrobial Agents and Chemotherapy, 62 (3) e01972, e01972-17. doi: 10.1128/AAC.01972-17
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William N. (2017). Hospital pharmacists’ and patients’ views about what constitutes effective communication between pharmacists and patients. International Journal of Pharmacy Practice, 26 (5), 450-457. doi: 10.1111/ijpp.12423
Barras, M.A. (2017). A word to the wise. Pharmacy GRIT, Autumn, 16-18.
Individualised medicine: why we need Bayesian dosing
Donagher, Joni, Martin, Jennifer H. and Barras, Michael A. (2017). Individualised medicine: why we need Bayesian dosing. Internal Medicine Journal, 47 (5), 593-600. doi: 10.1111/imj.13412
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2017). Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling. Health Expectations, 20 (5), 1121-1132. doi: 10.1111/hex.12558
Paradissis, Chariclia, Coombes, Ian D., Donovan, Peter, Doran, Elizabeth, Mckean, Mitchell and Barras, Michael A. (2017). The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay. Journal of Pharmacy Practice and Research, 47 (5), 347-354. doi: 10.1002/jppr.1255
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2017). A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Supportive Care in Cancer, 25 (2), 1-7. doi: 10.1007/s00520-016-3445-2
Barras, Michael and Legg, Amy (2017). Drug dosing in obese adults. Australian Prescriber, 40 (5), 189-193. doi: 10.18773/austprescr.2017.053
Bayesian estimation of tobramycin exposure in cystic fibrosis
Barras, Michael A., Serisier, David, Hennig, Stefanie, Jess, Katrina and Norris, Ross L. G. (2016). Bayesian estimation of tobramycin exposure in cystic fibrosis. Antimicrobial Agents and Chemotherapy, 60 (11), 6698-6702. doi: 10.1128/AAC.01131-16
Inpatient smoking cessation – turn to your clinical pharmacist
Snoswell, Centaine and Barras, Michael (2016). Inpatient smoking cessation – turn to your clinical pharmacist. Australian and New Zealand Journal of Public Health, 40 (5), 498-498. doi: 10.1111/1753-6405.12567
Barras, Michael A., Hughes, David and Ullner, Melanie (2016). Direct oral anticoagulants: new drugs with practical problems. How can nurses help prevent patient harm?. Nursing and Health Sciences, 18 (3), 408-411. doi: 10.1111/nhs.12263
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2016). Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework. Research in Social and Administrative Pharmacy, 12 (5), 747-755. doi: 10.1016/j.sapharm.2015.10.008
Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital
Petrie, S., Barras, M., Lust, K., Fagermo, N., Allen, J. and Martin, J. H. (2016). Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital. Internal Medicine Journal, 46 (7), 826-833. doi: 10.1111/imj.13117
New oral anticoagulants: appropriateness of prescribing in real-world setting
Pattullo, C. S., Barras, M., Tai, B., McKean, M. and Donovan, P. (2016). New oral anticoagulants: appropriateness of prescribing in real-world setting. Internal Medicine Journal, 46 (7), 812-818. doi: 10.1111/imj.13118
Dekker, Katharine R., Myers, Brooke L. and Barras, Michael A. (2016). Compliance with enoxaparin dosing and monitoring guidelines and the impact on patient length of stay: a pilot study. Therapeutic Drug Monitoring, 38 (1), 59-63. doi: 10.1097/FTD.0000000000000233
Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing
Mudge, Alison, Radnedge, Katherine, Kasper, Karen, Mullins, Robert, Adsett, Julie, Rofail, Serena, Lloyd, Sophie and Barras, Michael (2016). Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Australian Health Review, 40 (1), 86-91. doi: 10.1071/AH14219
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P and Kennedy, Glen A (2015). A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Blood, 126 (23), 1910-1910. doi: 10.1182/blood.v126.23.1910.1910
Hospital pharmacists' perceptions of medication counseling: a focus group study
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neill (2015). Hospital pharmacists' perceptions of medication counseling: a focus group study. Research in Social and Administrative Pharmacy, 12 (5), 756-771. doi: 10.1016/j.sapharm.2015.10.007
Lindsay, Julian N. and Barras, Michael (2015). Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy. Journal of Oncology Pharmacy Practice, 21 (4), 293-295. doi: 10.1177/1078155214527859
Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients
Marotti, Sally B., Barras, Michael and Kirkpatrick, Carl (2015). Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Therapeutic Drug Monitoring, 37 (1), 33-39. doi: 10.1097/FTD.0000000000000099
Engaging pharmacists in clinical research
Barras, Michael (2015). Engaging pharmacists in clinical research. Australian Journal of Pharmacy, 96 (1139)
Improving Care Transitions in Individuals Frequently Admitted to the Hospital
Mudge, Alison M., Barras, Michael, Adsett, Julie, Mullins, Robert W., Lloyd, Sophie and Kasper, Karen (2014). Improving Care Transitions in Individuals Frequently Admitted to the Hospital. Journal of the American Geriatrics Society, 62 (10), 1994-1996. doi: 10.1111/jgs.13033
Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison, Khatun, Mohsina and Barras, Michael (2014). The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Supportive Care in Cancer, 23 (1), 71-78. doi: 10.1007/s00520-014-2322-0
Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison and Barras, Michael (2014). Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Supportive Care in Cancer, 22 (4), 1113-1119. doi: 10.1007/s00520-013-2098-7
Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective
Jamsen, Kris M., McLeay, Sarah C., Barras, Michael A. and Green, Bruce (2014). Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective. Clinical Pharmacokinetics, 53 (2), 111-122. doi: 10.1007/s40262-013-0114-1
Barras, Michael, Moore, Diana, Pocock, Daniel, Sweedman, Myles, Wilkinson, Cathy, Taylor, Kerry and Morton, James (2013). Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting. Journal of Oncology Pharmacy Practice, OnlineFirst (5), 1-10. doi: 10.1177/1078155213504443
Abnormal laboratory results: anti-Xa assays
Barras, Michael (2013). Abnormal laboratory results: anti-Xa assays. Australian Prescriber, 36 (3), 98-101. doi: 10.18773/austprescr.2013.036
Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?
Iedema, Joel, Barras, Michael, Sundac, Lana and Coombes, Ian (2012). Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?. Australian Prescriber, 35 (2), 64-65. doi: 10.18773/austprescr.2012.029
Martin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146
Gentamicin use - more clinical outcome evidence needed
Martin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110
Recurrent readmissions in medical patients: A prospective study
Mudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811
Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis
Barras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x
Norris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a
Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846
Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x
Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.
Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins
Al-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x
Myalgia in patients on high-dose and low-to-moderate dose statin therapy
Gujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x
Preliminary results of a therapeutic drug monitoring survey in Australasia
Norris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167
Individualized compared with conventional dosing of enoxaparin
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399
Individualised vs conventional enoxaparin dosing
Barras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1), 77-81. doi: 10.1002/j.2055-2335.2008.tb00803.x
Gardner, A. Scott, Martin, James C., Martin, David T., Barras, Martin and Jenkins, 47517 (2007). Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests. European Journal of Applied Physiology, 101 (3), 287-292. doi: 10.1007/s00421-007-0498-4
General practitioner referral letters: are we getting the full picture?
Toleman, J. and Barras, M. (2007). General practitioner referral letters: are we getting the full picture?. Internal Medicine Journal, 37 (7), 510-511. doi: 10.1111/j.1445-5994.2007.01416.x
Pharmacists investigating adverse penicillin responses - Pilot Study
Roberts, Jason A., Hsu, Millie, Allen, Karen, Willis, Jennifer and Barras, Michael (2007). Pharmacists investigating adverse penicillin responses - Pilot Study. Journal of Pharmacy Practice and Research, 37 (3), 200-203. doi: 10.1002/j.2055-2335.2007.tb00744.x
Are patients on long-term corticosteroids receiving bone loss therapy?
Rofail, Serena and Barras, Michael A. (2006). Are patients on long-term corticosteroids receiving bone loss therapy?. Journal of Pharmacy Practice and Research, 36 (1), 29-31. doi: 10.1002/j.2055-2335.2006.tb00882.x
Patients' understanding of drug allergy and documentation: Is there a link?
Sim, Lily, Barras, Michael and Cottrell, Neil (2005). Patients' understanding of drug allergy and documentation: Is there a link?. Journal of Pharmacy Practice and Research, 35 (4), 276-278. doi: 10.1002/j.2055-2335.2005.tb00362.x
Teaching people with Parkinson's disease about their medication
O'Maley, Karen, O'Sullivan, John, Wollin, Judy, Barras, Michael and Brammer, Jillian (2005). Teaching people with Parkinson's disease about their medication. Nursing Older People, 17 (1) doi: 10.7748/nop2005.03.17.1.14.c2357
Effective conference presentations
Lum, E. and Barras, M.A. (2004). Effective conference presentations. Journal of Pharmacy Practice and Research, 34 (2), 157-158.
Paradissis, Chariclia, De Guzman, Keshia R., Barras, Michael, La Caze, Adam, Winckel, Karl, Taufatofua, Natasha and Falconer, Nazanin (2022). A qualitative study of the experiences of a pharmacy team working collaboratively in a COVID-19 vaccination service. 61st PAH Health Symposium, Brisbane, QLD Australia, 23-26 August 2022.
Validation and updating of the adverse inpatient medication event (AIME) model
Falconer, N., Scott, I., Abdel-Hafez, A., Snoswell, C., Cottrell, N., Morris, C., Lam, J. and Barras, M. (2021). Validation and updating of the adverse inpatient medication event (AIME) model. Australasian Pharmaceutical Science Association (APS) Conference, Online, 6-8 December 2021. Adelaide, SA, Australia: Bellberry.
Smareglia, L., Ghahreman-Falconer, N., Barras, M., Currey, E. and Snoswell, C. (2021). Evaluation of the Collaborative Ordering of Medications (COOM) pharmacist-physician model of care at the point of discharge in a digital hospital. 60th Princess Alexandra Hospital (PAH) Health Symposium: Embracing diversity in healthcare, Brisbane, QLD Australia, 24 - 27 August 2021. Brisbane, QLD Australia: Metro South Health.
A new Pharmacy discharge model in transit care hub improves patient flow.
Wang, N. and Barras, M. (2019). A new Pharmacy discharge model in transit care hub improves patient flow. . National Medicines Management , Gold Coast, QLD, Australia, 2019.
Banks, Vivien, Snoswell, Centaine L. and Barras, Michael (2019). Changes in service costs and time efficiencies when technicians practice at advanced scope, a systematic review. The Society of Hospital Pharmacists of Australia (SHPA) Qld Branch: 2019 Pharmacy Research Symposium, Brisbane, Australia, 26 October 2019.
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
Van Oosterom, N., Barras, M. and Winckel, K. (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Princess Alexandra Hospital (PAH) Health Symposium., Brisbane, QLD, Australia, 31 July 2019.
Final foundation residency portfolio reviews – Feedback from a two-site review process
Woodruff, Gemma, Hendy, Anna, Coombes, Judith, Winckel, Karl, Hale, Andrew, Coombes, Ian and Barras, Michael (2019). Final foundation residency portfolio reviews – Feedback from a two-site review process. APSA 2019, Melbourne, Australia, 1-4 December 2019.
NOAC's it's time to extenuate patient knowledge gaps
Steel, L., Faint, A., Barras, M., Cottrell, N., Parnell, M., Macey, B. and Yip, H. (2019). NOAC's it's time to extenuate patient knowledge gaps. 67th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, Adelaide, SA Australia, 8-11 August 2019. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2019.06.204
Pharmacy technicians practicing at advanced scope, who benefits?
Snoswell, Centaine L., Barras, Michael and Banks, Vivien (2019). Pharmacy technicians practicing at advanced scope, who benefits?. Medicines Management 2019: 45th SHPA Conference 2019, Gold Coast, QLD Australia, 15th November 2019.
Falconer, N., Barras, M., Abdel-Hafez, A., Radburn, S. and Cottrell, N. (2019). Prioritising hospital patients at high-risk of medication harm: development and validation of a predictive risk model. 14th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Stockholm, Sweden, 29 June - 2 July, 2019. Heidelberg, Germany: Springer. doi: 10.1007/s00228-019-02685-2
Keates, B. and Barras, M. A. (2019). Relationship between medication adherence and beliefs around health, medicines, and health locus of control in outpatients with cardiovascular disease. . Medicines Management, Gold Coast, QLD, Australia, 2019.
Strategies to best manage anticoagulants in an electronic medical record
Austin, J. and Barras, M. (2019). Strategies to best manage anticoagulants in an electronic medical record. National Medicines Management, Gold Coast, QLD, Australia, 2019.
Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital
George, C., Winckel, K., Barras, M., Coombes, J. and Cottrell, N. (2018). Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital. Translational Research Institute Symposium, Brisbane, QLD, Australia, August 2018.
Identifying Clinical Pharmacist Patient Prioritisation Criteria
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying Clinical Pharmacist Patient Prioritisation Criteria. Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Brisbane QLD Australia, December 2017.
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores. Society of Hospital Pharmacists of Australia conference, Sydney, Australia, November 2017.
The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2017). The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis. Australian Society of Clinical Pharmacology and Toxicology National Conference, Brisbane, QLD, Australia, 5 – 8 December 2017.
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology.
Implementation and Evaluation of an Interprofessional Curriculum
Cottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518
Norris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba
O’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043
A survey of therapeutic drug monitoring in Australasia
Norris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b
A survey of therapeutic drug monitoring in Australia and New Zealand
Norris, R., Morris, R., Ray, J., Ilett, K.F., Fullinfaw, R., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2008). A survey of therapeutic drug monitoring in Australia and New Zealand. Australasian Association of Clinical Biochemists’ 45th Annual Scientific Conference, Adelaide, South Australia, 16-19 September 2008. Mt. Lawley, W.A., Australia: Australasian Association of Clinical Biochemists.
Individualized compared with conventional dosing of enoxaparin
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Population Approach Group in Europe (PAGE) Conference, Marseille, France, June 2008. Leiden: Population Approach Group in Europe.
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy derived from population PK modelling and simulation. Population Approach Group in Australia and New Zealand (PAGANZ) Conference, Dunedin, Otago, New Zealand, 13-15 February 2008.
The evaluation of an individualised dosing strategy for enoxaparin
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy for enoxaparin. The 34th Society of Hospital Pharmacists of Australia (SHPA) National Conference, Adelaide Australia, September 2008.
A Population PKPD Model for Bleeding Events with Enoxaparin
Barras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. 2007 AAPS Annual Meeting and Exposition, San Diego California, 11th-15th November, 2007.
Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapy
Gujral, G., Barras, M. and Cottrell, W. N. (2007). Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapy. Medicines: Design to Delivery. Manly 2007 2nd Annual Conference of The Australasian Pharmaceutical Science Association, Manly, NSW, Australia, 8-11 December 2007. Australian Pharmaceutical Science Association (APSA).
Milk, bread and NSAIDs: The shopping list of 2004. Measuring the impact of open sale NSAIDs.
Windsor, S.N., Barras, M. A. and Rofail, S. (2004). Milk, bread and NSAIDs: The shopping list of 2004. Measuring the impact of open sale NSAIDs.. SHPA Qld Branch Conference, Toowoomba, 16-18 July 2004. Australia: SHPA.
Dose individualisation of enoxaparin
Michael Barras (2009). Dose individualisation of enoxaparin. PhD Thesis, Pharmacy school, The University of Queensland.
REducing hospital re-admission for high-risk CARDiology patients
(2023–2027) MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
(2023) Metro South Hospital and Health Service
(2019–2021) Metro South Hospital and Health Service
Medication harm in patients after Acute Myocardial Infarction
Doctor Philosophy — Principal Advisor
Other advisors:
A pharmacist to improve medication management and patient outcomes for critically ill patients in the emergency department.
Doctor Philosophy — Principal Advisor
Other advisors:
Patient-Centred Pharmacy Care in the hospital setting
Doctor Philosophy — Principal Advisor
Other advisors:
Electronic medication management of anticoagulants and its impact on clinical outcomes
Doctor Philosophy — Principal Advisor
Other advisors:
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Master Philosophy — Associate Advisor
Other advisors:
Quality and Safe Use of Clozapine
Doctor Philosophy — Associate Advisor
Implementing a Medication review pharmacy clinic and the potential impact on patient care.
Doctor Philosophy — Associate Advisor
Other advisors:
Evaluation of a multidisciplinary stewardship program to reduce hospital-acquired VTE in MSH
Master Philosophy — Associate Advisor
Other advisors:
Development and Integration of a Medication Harm Prediction Tool within an Australian Digital Hospital
Doctor Philosophy — Associate Advisor
Other advisors:
Aspirin for the Prophylaxis of Venous Thromboembolic Events
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
(2022) Doctor Philosophy — Associate Advisor
(2020) Doctor Philosophy — Associate Advisor
Other advisors:
(2017) Doctor Philosophy — Associate Advisor